Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 12
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Chimeras taking shape: potential functions of proteins encoded by chimeric RNA transcripts

  • Frenkel-Morgenstern, Milana
  • Lacroix, Vincent
  • Ezkurdia, Iakes
  • Levin, Yishai
  • Gabashvili, Alexandra
  • Prilusky, Jaime
  • Pozo, Angela del
  • Tress, Michael
  • Johnson, Rory
  • Guigó Serra, Roderic
  • Valencia, Alfonso
Chimeric RNAs comprise exons from two or more different genes and have the potential to encode novel proteins that alter cellular phenotypes. To date, numerous putative chimeric transcripts have been identified among the ESTs isolated from several organisms and using high throughput RNA sequencing. The few corresponding protein products that have been characterized mostly result from chromosomal translocations and are associated with cancer. Here, we systematically establish that some of the putative chimeric transcripts are genuinely expressed in human cells. Using high throughput RNA sequencing, mass spectrometry experimental data, and functional annotation, we studied 7424 putative human chimeric RNAs. We confirmed the expression of 175 chimeric RNAs in 16 human tissues, with an abundance varying from 0.06 to 17 RPKM (Reads Per Kilobase per Million mapped reads). We show that these chimeric RNAs are significantly more tissue-specific than non-chimeric transcripts. Moreover, we present evidence that chimeras tend to incorporate highly expressed genes. Despite the low expression level of most chimeric RNAs, we show that 12 novel chimeras are translated into proteins detectable in multiple shotgun mass spectrometry experiments. Furthermore, we confirm the expression of three novel chimeric proteins using targeted mass spectrometry. Finally, based on our functional annotation of exon organization and preserved domains, we discuss the potential features of chimeric proteins with illustrative examples and suggest that chimeras significantly exploit signal peptides and transmembrane domains, which can alter the cellular localization of cognate proteins. Taken together, these findings establish that some chimeric RNAs are translated into potentially functional proteins in humans., The work of M.F-M. is supported by the CNIO (Caja Navarra International Postdoctoral Program) and the Miguel Servet (FIS) grant. The work of V.L. is supported by the French ANR MIRI BLAN08-1335497 Project and the ERC Advanced Grant Sisyphe. This study is supported by the Spanish National Bioinformatics Institute (INB-ISCIII) and by grants from the Spanish Government (CONSOLIDER CSD2007-00050, BIO2007-666855, and BIO2011-26205), European Commission FP7 project ASSET (HEALTH-F4-2010-259348), and the NHGRI-NIH ENCODE grants (U54 HG00455-04 and U54 HG004557)
Repisalud
Publication Artículo científico (JournalArticle)

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

  • Ferreira, Manuel A
  • Gamazon, Eric R
  • Al-Ejeh, Fares
  • Aittomäki, Kristiina
  • Andrulis, Irene L
  • Anton-Culver, Hoda
  • Arason, Adalgeir
  • Arndt, Volker
  • Aronson, Kristan J
  • Arun, Banu K
  • Asseryanis, Ella
  • Azzollini, Jacopo
  • Balmaña, Judith
  • Barnes, Daniel R
  • Barrowdale, Daniel
  • Beckmann, Matthias W
  • Behrens, Sabine
  • Benitez, Javier
  • Bermisheva, Marina
  • Białkowska, Katarzyna
  • Blomqvist, Carl
  • Bogdanova, Natalia V
  • Bojesen, Stig E
  • Bolla, Manjeet K
  • Borg, Ake
  • Brauch, Hiltrud
  • Brenner, Hermann
  • Broeks, Annegien
  • Burwinkel, Barbara
  • Caldés, Trinidad
  • Caligo, Maria A
  • Campa, Daniele
  • Campbell, Ian
  • Canzian, Federico
  • Carter, Jonathan
  • Carter, Brian D
  • Castelao, Jose E
  • Chang-Claude, Jenny
  • Chanock, Stephen J
  • Christiansen, Hans
  • Chung, Wendy K
  • Claes, Kathleen B M
  • Clarke, Christine L
  • Couch, Fergus J
  • Cox, Angela
  • Cross, Simon S
  • Czene, Kamila
  • Daly, Mary B
  • de la Hoya, Miguel
  • Dennis, Joe
  • Devilee, Peter
  • Diez, Orland
  • Dörk, Thilo
  • Dunning, Alison M
  • Dwek, Miriam
  • Eccles, Diana M
  • Ejlertsen, Bent
  • Ellberg, Carolina
  • Engel, Christoph
  • Eriksson, Mikael
  • Fasching, Peter A
  • Fletcher, Olivia
  • Flyger, Henrik
  • Friedman, Eitan
  • Frost, Debra
  • Gabrielson, Marike
  • Gago-Dominguez, Manuela
  • Ganz, Patricia A
  • Gapstur, Susan M
  • Garber, Judy
  • García-Closas, Montserrat
  • García-Sáenz, José A
  • Gaudet, Mia M
  • Giles, Graham G
  • Glendon, Gord
  • Godwin, Andrew K
  • Goldberg, Mark S
  • Goldgar, David E
  • González-Neira, Anna
  • Greene, Mark H
  • Gronwald, Jacek
  • Guénel, Pascal
  • Haiman, Christopher A
  • Hall, Per
  • Hamann, Ute
  • He, Wei
  • Heyworth, Jane
  • Hogervorst, Frans B L
  • Hollestelle, Antoinette
  • Hoover, Robert N
  • Hopper, John L
  • Hulick, Peter J
  • Humphreys, Keith
  • Imyanitov, Evgeny N
  • Isaacs, Claudine
  • Jakimovska, Milena
  • Jakubowska, Anna
  • James, Paul A
  • Janavicius, Ramunas
  • Jankowitz, Rachel C
  • John, Esther M
  • Johnson, Nichola
  • Joseph, Vijai
  • Karlan, Beth Y
  • Khusnutdinova, Elza
  • Kiiski, Johanna I
  • Ko, Yon-Dschun
  • Jones, Michael E
  • Konstantopoulou, Irene
  • Kristensen, Vessela N
  • Laitman, Yael
  • Lambrechts, Diether
  • Lazaro, Conxi
  • Leslie, Goska
  • Lester, Jenny
  • Lesueur, Fabienne
  • Lindström, Sara
  • Long, Jirong
  • Loud, Jennifer T
  • Lubiński, Jan
  • Makalic, Enes
  • Mannermaa, Arto
  • Manoochehri, Mehdi
  • Margolin, Sara
  • Maurer, Tabea
  • Mavroudis, Dimitrios
  • McGuffog, Lesley
  • Meindl, Alfons
  • Menon, Usha
  • Michailidou, Kyriaki
  • Miller, Austin
  • Montagna, Marco
  • Moreno, Fernando
  • Moserle, Lidia
  • Mulligan, Anna Marie
  • Nathanson, Katherine L
  • Neuhausen, Susan L
  • Nevanlinna, Heli
  • Nevelsteen, Ines
  • Nielsen, Finn C
  • Nikitina-Zake, Liene
  • Nussbaum, Robert L
  • Offit, Kenneth
  • Olah, Edith
  • Olopade, Olufunmilayo I
  • Olsson, Håkan
  • Osorio, Ana
  • Papp, Janos
  • Park-Simon, Tjoung-Won
  • Parsons, Michael T
  • Pedersen, Inge Sokilde
  • Peixoto, Ana
  • Peterlongo, Paolo
  • Pharoah, Paul D P
  • Plaseska-Karanfilska, Dijana
  • Poppe, Bruce
  • Presneau, Nadege
  • Radice, Paolo
  • Rantala, Johanna
  • Rennert, Gad
  • Risch, Harvey A
  • Saloustros, Emmanouil
  • Sanden, Kristin
  • Sawyer, Elinor J
  • Schmidt, Marjanka K
  • Schmutzler, Rita K
  • Sharma, Priyanka
  • Shu, Xiao-Ou
  • Simard, Jacques
  • Singer, Christian F
  • Soucy, Penny
  • Southey, Melissa C
  • Spinelli, John J
  • Spurdle, Amanda B
  • Stone, Jennifer
  • Swerdlow, Anthony J
  • Tapper, William J
  • Taylor, Jack A
  • Teixeira, Manuel R
  • Terry, Mary Beth
  • Teulé, Alex
  • Thomassen, Mads
  • Thöne, Kathrin
  • Thull, Darcy L
  • Tischkowitz, Marc
  • Toland, Amanda E
  • Torres, Diana
  • Truong, Thérèse
  • Tung, Nadine
  • Vachon, Celine M
  • van Asperen, Christi J
  • van den Ouweland, Ans M W
  • van Rensburg, Elizabeth J
  • Vega, Ana
  • Viel, Alessandra
  • Wang, Qin
  • Wappenschmidt, Barbara
  • Weitzel, Jeffrey N
  • Wendt, Camilla
  • Winqvist, Robert
  • Yang, Xiaohong R
  • Yannoukakos, Drakoulis
  • Ziogas, Argyrios
  • Kraft, Peter
  • Antoniou, Antonis C
  • Zheng, Wei
  • Easton, Douglas F
  • Milne, Roger L
  • Beesley, Jonathan
  • Chenevix-Trench, Georgia
Genome-wide association studies (GWAS) have identified more than 170 breast cancer susceptibility loci. Here we hypothesize that some risk-associated variants might act in non-breast tissues, specifically adipose tissue and immune cells from blood and spleen. Using expression quantitative trait loci (eQTL) reported in these tissues, we identify 26 previously unreported, likely target genes of overall breast cancer risk variants, and 17 for estrogen receptor (ER)-negative breast cancer, several with a known immune function. We determine the directional effect of gene expression on disease risk measured based on single and multiple eQTL. In addition, using a gene-based test of association that considers eQTL from multiple tissues, we identify seven (and four) regions with variants associated with overall (and ER-negative) breast cancer risk, which were not reported in previous GWAS. Further investigation of the function of the implicated genes in breast and immune cells may provide insights into the etiology of breast cancer.
Repisalud
Publication Artículo científico (JournalArticle)

EWS-FLI1 impairs aryl hydrocarbon receptor activation by blocking tryptophan breakdown via the kynurenine pathway

  • Mutz, Cornelia N
  • Schwentner, Raphaela
  • Kauer, Maximilian O
  • Katschnig, Anna M
  • Kromp, Florian
  • Aryee, Dave N T
  • Erhardt, Sophie
  • Goiny, Michel
  • Alonso, Javier
  • Fuchs, Dietmar
  • Kovar, Heinrich
Ewing sarcoma (ES) is an aggressive pediatric tumor driven by the fusion protein EWS-FLI1. We report that EWS-FLI1 suppresses TDO2-mediated tryptophan (TRP) breakdown in ES cells. Gene expression and metabolite analyses reveal an EWS-FLI1-dependent regulation of TRP metabolism. TRP consumption increased in the absence of EWS-FLI1, resulting in kynurenine and kynurenic acid accumulation, both aryl hydrocarbon receptor (AHR) ligands. Activated AHR binds to the promoter region of target genes. We demonstrate that EWS-FLI1 knockdown results in AHR nuclear translocation and activation. Our data suggest that EWS-FLI1 suppresses autocrine AHR signaling by inhibiting TDO2-catalyzed TRP breakdown.
Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

  • Lázaro García, Conxi
  • GC-HBOC Study Collaborators
  • GEMO Study Collaborators
  • EMBRACE Collaborators
  • HEBON Investigators
  • BCFR Investigators
  • ABCTB Investigators
Genome-wide association studies (GWAS) have identified more than 170 breast cancer susceptibility loci. Here we hypothesize that some risk-associated variants might act in non-breast tissues, specifically adipose tissue and immune cells from blood and spleen. Using expression quantitative trait loci (eQTL) reported in these tissues, we identify 26 previously unreported, likely target genes of overall breast cancer risk variants, and 17 for estrogen receptor (ER)-negative breast cancer, several with a known immune function. We determine the directional effect of gene expression on disease risk measured based on single and multiple eQTL. In addition, using a gene-based test of association that considers eQTL from multiple tissues, we identify seven (and four) regions with variants associated with overall (and ER-negative) breast cancer risk, which were not reported in previous GWAS. Further investigation of the function of the implicated genes in breast and immune cells may provide insights into the etiology of breast cancer.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A common structural scaffold in CTD phosphatases that supports distinct catalytic mechanisms

  • Pons, Tirso
  • Paramonov, Ida
  • Boullosa, César
  • Ibáñez, Kristina
  • Rojas Mendoza, Ana M.
  • Valencia, Alfonso
The phosphorylation and dephosphorylation of the carboxyl-terminal domain (CTD) of the largest RNA polymerase II (RNAPII) subunit is a critical regulatory checkpoint for transcription and mRNA processing. This CTD is unique to eukaryotic organisms and it contains multiple tandem-repeats with the consensus sequence Tyr1–Ser2–Pro3–Thr4–Ser5–Pro6–Ser7. Traditionally, CTD phosphatases that use metal-ion-independent (cysteine-based) and metal-ion-assisted (aspartate-based) catalytic mechanisms have been considered to belong to two independent groups. However, using structural comparisons we have identified a common structural scaffold in these two groups of CTD phosphatases. This common scaffold accommodates different catalytic processes with the same substrate specificity, in this case phospho-serine/threonine residues flanked by prolines. Furthermore, this scaffold provides a structural connection between two groups of protein tyrosine phosphatases (PTPs): Cys-based (classes I, II, and III) and Asp-based (class IV) PTPs. Redundancy in catalytic mechanisms is not infrequent and may arise in specific biological settings. To better understand the activity of the CTD phosphatases, we combined our structural analyses with data on CTD phosphatase expression in different human and mouse tissues. The results suggest that aspartate- and cysteine-based CTD-dephosphorylation acts in concert during cellular stress, when high levels of reactive oxygen species can inhibit the nucleophilic function of the catalytic cysteine, as occurs in mental and neurodegenerative disorders like schizophrenia, Alzheimer's and Parkinson's diseases. Moreover, these findings have significant implications for the study of the RNAPII-CTD dephosphorylation in eukaryotes. Proteins 2014; 82:103–118. © 2013 Wiley Periodicals, Inc., Grant sponsor: EU FP7 ASSET project; Grant number: 259348 (to AV); Grant sponsor: Obra Social laCaixa (to KI); Grant sponsor: FPI; Grant number: BES- 2008-006332 (to CB)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Uncovering the Molecular Machinery of the Human Spindle—An Integration of Wet and Dry Systems Biology

  • Rojas Mendoza, Ana M.
  • Ranea, Juan A. G.
Rojas, A. M. et al., The mitotic spindle is an essential molecular machine involved in cell division, whose composition has been studied extensively by detailed cellular biology, high-throughput proteomics, and RNA interference experiments. However, because of its dynamic organization and complex regulation it is difficult to obtain a complete description of its molecular composition. We have implemented an integrated computational approach to characterize novel human spindle components and have analysed in detail the individual candidates predicted to be spindle proteins, as well as the network of predicted relations connecting known and putative spindle proteins. The subsequent experimental validation of a number of predicted novel proteins confirmed not only their association with the spindle apparatus but also their role in mitosis. We found that 75% of our tested proteins are localizing to the spindle apparatus compared to a success rate of 35% when expert knowledge alone was used. We compare our results to the previously published MitoCheck study and see that our approach does validate some findings by this consortium. Further, we predict so-called “hidden spindle hub”, proteins whose network of interactions is still poorly characterised by experimental means and which are thought to influence the functionality of the mitotic spindle on a large scale. Our analyses suggest that we are still far from knowing the complete repertoire of functionally important components of the human spindle network. Combining integrated bio-computational approaches and single gene experimental follow-ups could be key to exploring the still hidden regions of the human spindle system., This work was supported by ENFIN, a Network of Excellence funded by the European Commission within its FP6 Programme, under the thematic area “Life sciences, genomics and biotechnology for health,” contract number LSHG-CT-2005-518254. This project was also supported by Interaction Proteome (contract number LSHG-CT-2003-505520). AR is funded by Spanish Ministry of Science and Innovation FIS PS09/02111. AC acknowledges funding from the EMBRACE European Network of Excellence. AMR acknowledges funding from PS09/02111 from the Spanish Ministry of Science and Innovation. JAGR is funded by EU-FP7-Systems Microscopy NoE (grant agreement n°258068), by the SAF2009-09839 project and the Ramon y Cajal program (RYC-2007-01649) from Ministerio de Ciencia e Innovación, Spain. This study is also funded by FP7–HEALTH–2010-two-stage Grant Agreement Number 259348 ASSET: Analysing and Striking the Sensitivities of Embryonal Tumours (HEALTH-F4-2010-259348)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Germline mutations in FAN1 cause hereditary colorectal cancer by impairing DNA repair

  • Seguí, Nuria
  • Mina, Leonardo B.
  • Durán, Mercedes
  • Lastra, Enrique
  • Blanco, Ignacio
  • Valle, Laura
Under a Creative Commons license.-- et al., Identification of genes associated with hereditary cancers facilitates management of patients with family histories of cancer. We performed exome sequencing of DNA from 3 individuals from a family with colorectal cancer who met the Amsterdam criteria for risk of hereditary nonpolyposis colorectal cancer. These individuals had mismatch repair-proficient tumors and each carried nonsense variant in the FANCD2/FANCI-associated nuclease 1 gene (FAN1), which encodes a nuclease involved in DNA inter-strand cross-link repair. We sequenced FAN1 in 176 additional families with histories of colorectal cancer and performed in vitro functional analyses of the mutant forms of FAN1 identified. We detected FAN1 mutations in approximately 3% of families who met the Amsterdam criteria and had mismatch repair-proficient cancers with no previously associated mutations. These findings link colorectal cancer predisposition to the Fanconi anemia DNA repair pathway, supporting the connection between genome integrity and cancer risk., This work was funded by the Spanish Ministry of Economy and Competitiveness (SAF2012-38885 [LV], SAF2012-31881 [JS], SAF2013-45836R [XSP] and SAF2012-33636 [GC] and Ramón y Cajal Contract to LV); the Carlos III Health Institute (PI11-01439 [VM], PI13/00285 [CL] and fellowship to NS); CIBERESP (CB07/02/2005 [VM]); RTICC (RD12/0036/0031, RD12/0036/0006, RD12/0036/0008 and RD12/0036/0067); the EU FP7 project ASSET (grant agreement 259348 to AV); L’Oréal-UNESCO “For Women in Science”; the Scientific Foundation Asociación Española Contra el Cáncer; and the Government of Catalonia (2014SGR338 [GC] and 2009SGR0489 [JS]). JS is also funded by ICREA Academia and the European Regional Development FEDER Funds. CIBERER is an initiative of the Carlos III Health Institute., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Association between germline mutations in BRF1, a subunit of the RNA polymerase III transcription complex, and hereditary colorectal cancer

  • Bellido, Fernando
  • Sowada, Nadine
  • Mur, Pilar
  • Lázaro, Conxi
  • Pons, Tirso
  • Valdés-Mas, Rafael
  • Pineda, Marta
  • Aiza, Gemma
  • Iglesias, Silvia
  • Soto, José Luis
  • Urioste, Miguel
  • Caldés, Trinidad
  • Balbín, Milagros
  • Blay, Pilar
  • Rueda, Daniel
  • Durán, Mercedes
  • Valencia, Alfonso
  • Moreno, Victor
  • Brunet, Joan
  • Blanco, Ignacio
  • Navarro, Matilde
  • Calin, George G.
  • Borck, Guntram
  • Puente, Xose S.
  • Capellá, Gabriel
  • Valle, Laura
[Background & Aims] Although there is a genetic predisposition to colorectal cancer (CRC), few of the genes that affect risk have been identified. We performed whole-exome sequence analysis of individuals in a high-risk family without mutations in genes previously associated with CRC risk to identify variants associated with inherited CRC., [Methods] We collected blood samples from 3 relatives with CRC in Spain (65, 62, and 40 years old at diagnosis) and performed whole-exome sequence analyses. Rare missense, truncating or splice-site variants shared by the 3 relatives were selected. We used targeted pooled DNA amplification followed by next generation sequencing to screen for mutations in candidate genes in 547 additional hereditary and/or early-onset CRC cases (502 additional families). We carried out protein-dependent yeast growth assays and transfection studies in the HT29 human CRC cell line to test the effects of the identified variants., [Results] A total of 42 unique or rare (population minor allele frequency below 1%) nonsynonymous genetic variants in 38 genes were shared by all 3 relatives. We selected the BRF1 gene, which encodes an RNA polymerase III transcription initiation factor subunit for further analysis, based on the predicted effect of the identified variant and previous association of BRF1 with cancer. Previously unreported or rare germline variants in BRF1 were identified in 11 of 503 CRC families, a significantly greater proportion than in the control population (34 of 4300). Seven of the identified variants (1 detected in 2 families) affected BRF1 mRNA splicing, protein stability, or expression and/or function., [Conclusions] In an analysis of families with a history of CRC, we associated germline mutations in BRF1 with predisposition to CRC. We associated deleterious BRF1 variants with 1.4% of familial CRC cases, in individuals without mutations in high-penetrance genes previously associated with CRC. Our findings add additional evidence to the link between defects in genes that regulate ribosome synthesis and risk of CRC., This work was funded by the Spanish Ministry of Economy and Competitiveness, co-funded by FEDER funds—a way to build Europe (SAF2016–80888-R [LV], SAF2013–45836-R [XSP], SAF2015–68016-R [GC and MP], and Juan de la Cierva contract [PM]); Carlos III National Health Institute (PI16/00563 [CL], PI11/01439 [VM], PI14/00459 [MU], and CIBERONC); Government of Catalonia (2014SGR338, 2014SGR647); Catalan Department of Health (PERIS); the EU FP7 project ASSET (grant agreement 259348 [AV]); Joint BSC-IRB-CRG Program in Computational Biology; Severo Ochoa Award (SEV 2015-0493 [AV]) and Scientific Foundation Asociación Española Contra el Cáncer., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

The second European interdisciplinary Ewing sarcoma research summit - A joint effort to deconstructing the multiple layers of a complex disease

  • Kovar, Heinrich
  • Amatruda, James
  • Brunet, Erika
  • Burdach, Stefan
  • Cidre-Aranaz, Florencia
  • Álava, Enrique de
  • Dirksen, Uta
  • van der Ent, Wietske
  • Grohar, Patrick
  • Grünewald, Thomas G. P.
  • Helman, Lee
  • Houghton, Peter
  • Iljin, Kristiina
  • Korsching, Eberhard
  • Ladanyi, Marc
  • Lawlor, Elizabeth
  • Lessnick, Stephen
  • Ludwig, Joseph
  • Meltzer, Paul
  • Meltzer, Markus
  • Mora, Jaume
  • Moriggl, Richard
  • Nakamura, Takuro
  • Papamarkou, Theodore
  • Sarikas, Branka Radic
  • Rédini, Francoise
  • Richter, Guenther H. S.
  • Rossig, Claudia
  • Schadler, Keri
  • Schäfer, Beat W.
  • Scotlandi, Katia
  • Sheffield, Nathan C.
  • Shelat, Anang
  • Snaar-Jagalska, Ewa
  • Sorensen, Poul
  • Stegmaier, Kimberly
  • Stewart, Elizabeth
  • Sweet-Cordero, Alejandro
  • Szuhai, Karoly
  • Tirado, Óscar M.
  • Tirode, Franck
  • Toretsky, Jeffrey
  • Tsafou, Kalliopi
  • Üren, Aykut
  • Zinovyev, Andrei
  • Delattre, Olivier
Despite multimodal treatment, long term outcome for patients with Ewing sarcoma is still poor. The second >European interdisciplinary Ewing sarcoma research summit> assembled a large group of scientific experts in the field to discuss their latest unpublished findings on the way to the identification of novel therapeutic targets and strategies. Ewing sarcoma is characterized by a quiet genome with presence of an EWSR1-ETS gene rearrangement as the only and defining genetic aberration. RNAsequencing of recently described Ewing-like sarcomas with variant translocations identified them as biologically distinct diseases. Various presentations adressed mechanisms of EWS-ETS fusion protein activities with a focus on EWS-FLI1. Data were presented shedding light on the molecular underpinnings of genetic permissiveness to this disease uncovering interaction of EWS-FLI1 with recently discovered susceptibility loci. Epigenetic context as a consequence of the interaction between the oncoprotein, cell type, developmental stage, and tissue microenvironment emerged as dominant theme in the discussion of the molecular pathogenesis and inter- and intratumor heterogeneity of Ewing sarcoma, and the difficulty to generate animal models faithfully recapitulating the human disease. The problem of preclinical development of biologically targeted therapeutics was discussed and promising perspectives were offered from the study of novel in vitro models. Finally, it was concluded that in order to facilitate rapid pre-clinical and clinical development of novel therapies in Ewing sarcoma, the community needs a platform to maintain knowledge of unpublished results, systems and models used in drug testing and to continue the open dialogue initiated at the first two Ewing sarcoma summits., The conference was supported by the European Union’s Seventh Framework Programme grants 261743(ENCCA) and 259348 (ASSET)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

DNA methylation heterogeneity defines a disease spectrum in Ewing sarcoma

  • Sheffield, Nathan C.
  • Pierron, Gaelle
  • Klughammer, Johanna
  • Datlinger, Paul
  • Schönegger, Andreas
  • Schuster, Michael
  • Hadler, Johanna
  • Surdez, Didier
  • Guillemot, Delphine
  • Lapouble, Eve
  • Freneaux, Paul
  • Champigneulle, Jacqueline
  • Bouvier, Raymonde
  • Walder, Diana
  • Ambros, Ingeborg M.
  • Hutter, Caroline
  • Sorz, Eva
  • Amaral, Ana Teresa
  • Álava, Enrique de
  • Schallmoser, Katharina
  • Strunk, Dirk
  • Rinner, Beate
  • Liegl-Atzwanger, Bernadette
  • Huppertz, Berthold
  • Leithner, Andreas
  • Pinieux, Gonzague de
  • Terrier, Philippe
  • Laurence, Valérie
  • Michon, Jean
  • Ladenstein, Ruth
  • Holter, Wolfgang
  • Windhager, Reinhard
  • Dirksen, Uta
  • Ambros, Peter F.
  • Delattre, Olivier
  • Kovar, Heinrich
  • Bock, Christoph
  • Tomazou, Eleni M.
Developmental tumors in children and young adults carry few genetic alterations, yet they have diverse clinical presentation. Focusing on Ewing sarcoma, we sought to establish the prevalence and characteristics of epigenetic heterogeneity in genetically homogeneous cancers. We performed genome-scale DNA methylation sequencing for a large cohort of Ewing sarcoma tumors and analyzed epigenetic heterogeneity on three levels: between cancers, between tumors, and within tumors. We observed consistent DNA hypomethylation at enhancers regulated by the disease-defining EWS-FLI1 fusion protein, thus establishing epigenomic enhancer reprogramming as a ubiquitous and characteristic feature of Ewing sarcoma. DNA methylation differences between tumors identified a continuous disease spectrum underlying Ewing sarcoma, which reflected the strength of an EWS-FLI1 regulatory signature and a continuum between mesenchymal and stem cell signatures. There was substantial epigenetic heterogeneity within tumors, particularly in patients with metastatic disease. In summary, our study provides a comprehensive assessment of epigenetic heterogeneity in Ewing sarcoma and thereby highlights the importance of considering nongenetic aspects of tumor heterogeneity in the context of cancer biology and personalized medicine., The following associations supported this work: Courir pour Mathieu, Dans les pas du Géant, Olivier Chape, Les Bagouzamanon, Enfants et Santé, and les Amis de Claire. The study was performed in the context of the following European Union consortia: Euro Ewing (grant agreement no. 602856), BLUEPRINT (grant agreement no. 282510), PROVABES (grant agreement no. 01KT1310), ASSET (grant agreement no. 259348), and TECHNOBEAT (grant agreement no. 668724). N.C.S. was supported by a long-term fellowship of the Human Frontier Science Program (LT000211/2014). J.K. was supported by a DOC Fellowship of the Austrian Academy of Sciences. D. Surdez was supported by the Institut Curie-SIRIC (Site de Recherche Intégrée en Cancérologie) program. E.d.A. was supported by Ministry of Economy and Competitiveness of Spain-FEDER grants (CIBERONC, RD12/0036/0017, PI14/01466), María García-Estrada, CRIS contra el Cáncer Foundations, and Pablo Ugarte Association. C.B. was supported by a New Frontiers Group award of the Austrian Academy of Sciences and by a European Research Council (ERC) Starting Grant (European Union's Horizon 2020 research and innovation program; grant 679146). E.M.T. was supported by fellowships of the Austrian Science Fund (FWF, Lise Meitner Fellowship M1448-B13; and Elise Richter Fellowship V506-B28).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Chimeras taking shape: potential functions of proteins encoded by chimeric RNA transcripts

  • Frenkel-Morgenstern, Milana
  • Lacroix, Vincent
  • Ezkurdia, Iakes
  • Levin, Yishai
  • Gabashvili, Alexandra
  • Prilusky, Jaime
  • Pozo, Angela del
  • Tress, Michael
  • Johnson, Rory
  • Guigó Serra, Roderic
  • Valencia, Alfonso
Chimeric RNAs comprise exons from two or more different genes and have the potential to encode novel proteins that alter cellular phenotypes. To date, numerous putative chimeric transcripts have been identified among the ESTs isolated from several organisms and using high throughput RNA sequencing. The few corresponding protein products that have been characterized mostly result from chromosomal translocations and are associated with cancer. Here, we systematically establish that some of the putative chimeric transcripts are genuinely expressed in human cells. Using high throughput RNA sequencing, mass spectrometry experimental data, and functional annotation, we studied 7424 putative human chimeric RNAs. We confirmed the expression of 175 chimeric RNAs in 16 human tissues, with an abundance varying from 0.06 to 17 RPKM (Reads Per Kilobase per Million mapped reads). We show that these chimeric RNAs are significantly more tissue-specific than non-chimeric transcripts. Moreover, we present evidence that chimeras tend to incorporate highly expressed genes. Despite the low expression level of most chimeric RNAs, we show that 12 novel chimeras are translated into proteins detectable in multiple shotgun mass spectrometry experiments. Furthermore, we confirm the expression of three novel chimeric proteins using targeted mass spectrometry. Finally, based on our functional annotation of exon organization and preserved domains, we discuss the potential features of chimeric proteins with illustrative examples and suggest that chimeras significantly exploit signal peptides and transmembrane domains, which can alter the cellular localization of cognate proteins. Taken together, these findings establish that some chimeric RNAs are translated into potentially functional proteins in humans., The work of M.F-M. is supported by the CNIO (Caja Navarra International Postdoctoral Program) and the Miguel Servet (FIS) grant. The work of V.L. is supported by the French ANR MIRI BLAN08-1335497 Project and the ERC Advanced Grant Sisyphe. This study is supported by the Spanish National Bioinformatics Institute (INB-ISCIII) and by grants from the Spanish Government (CONSOLIDER CSD2007-00050, BIO2007-666855, and BIO2011-26205), European Commission FP7 project ASSET (HEALTH-F4-2010-259348), and the NHGRI-NIH ENCODE grants (U54 HG00455-04 and U54 HG004557)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

  • Lázaro García, Conxi
  • GC-HBOC Study Collaborators
  • GEMO Study Collaborators
  • EMBRACE Collaborators
  • HEBON Investigators
  • BCFR Investigators
  • ABCTB Investigators
Genome-wide association studies (GWAS) have identified more than 170 breast cancer susceptibility loci. Here we hypothesize that some risk-associated variants might act in non-breast tissues, specifically adipose tissue and immune cells from blood and spleen. Using expression quantitative trait loci (eQTL) reported in these tissues, we identify 26 previously unreported, likely target genes of overall breast cancer risk variants, and 17 for estrogen receptor (ER)-negative breast cancer, several with a known immune function. We determine the directional effect of gene expression on disease risk measured based on single and multiple eQTL. In addition, using a gene-based test of association that considers eQTL from multiple tissues, we identify seven (and four) regions with variants associated with overall (and ER-negative) breast cancer risk, which were not reported in previous GWAS. Further investigation of the function of the implicated genes in breast and immune cells may provide insights into the etiology of breast cancer.